Tag Archives: Protagen

DORTMUND, Germany–(BUSINESS WIRE)–Protagen AG, technology leader in the development of novel molecular diagnostic and companion diagnostic tests for autoimmune diseases and oncological indications, announced today the identification of novel protein biomarkers in prostate cancer, which are potential drug targets supporting ...

Read More »